Author/Authors :
Ohashi، نويسنده , , Rina and Takahashi، نويسنده , , Fumiyuki and Cui، نويسنده , , Ri and Yoshioka، نويسنده , , Masakata and Gu، نويسنده , , Tao and Sasaki، نويسنده , , Shinichi and Tominaga، نويسنده , , Shigeru and Nishio، نويسنده , , Kazuto and Tanabe، نويسنده , , Kenneth K. and Takahashi، نويسنده , , Kazuhisa، نويسنده ,
Abstract :
CD44s is a principle hyaluronate (HA) receptor and has been reported to play an important role in cancer cell invasion and metastasis. The aim of our study is to determine if the interaction between HA and CD44s influences in vitro chemosensitivity of non-small cell lung cancer (NSCLC). NSCLC cell line, H322 cells, transfected with the CD44s gene (H322/CD44s) cultured on HA coated plates were more resistant to cisplatin (CDDP) than that on bovine serum albumin. Multidrug resistance protein2 (MRP2) expression was induced in H322/CD44s cells cultured on HA. MRP2 inhibitor, MK571, not only suppressed MRP2 expression but also reversed CDDP resistance. These results suggest that the interaction between CD44s and HA play a pivotal role in acquired resistance to CDDP in NSCLC and MRP2 could be involved in this potential mechanism.
Keywords :
Chemoresistance , CD44s , Hyaluronate , Non-small cell lung cancer , MRP2
